Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GIOVANNA M DA SILVA SOUTHWICK

Allopathic & Osteopathic Physicians Colon & Rectal Surgery

NPI
1770745028
CMS profile
125454
Location
WESTON, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$7,818.14

24 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Intuitive Surgical, Inc. $2,620.62 12
Davol Inc. $2,101.70 3
Takeda Pharmaceuticals U.S.A., Inc. $1,998.75 1
Medtronic, Inc. $1,074.17 7
Axonics, Inc. $22.90 1

Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GIOVANNA M DA SILVA SOUTHWICK

NPI 1770745028 · CMS profile ID 125454

Allopathic & Osteopathic Physicians / Colon & Rectal Surgery

WESTON, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1770745028?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GIOVANNA M DA SILVA SOUTHWICK, NPI 1770745028, CMS profile ID 125454. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1770745028?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). GIOVANNA M DA SILVA SOUTHWICK, NPI 1770745028, CMS profile ID 125454. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1770745028?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
GIOVANNA M DA SILVA SOUTHWICK, NPI 1770745028, CMS profile ID 125454, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–24 of 24 matching records. This page contains 24 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1770745028?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

24 matching records · $7,818.14 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 24 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–24 of 24.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Intuitive Surgical, Inc. $33.5012/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055418917 CMS
Intuitive Surgical, Inc. $119.9112/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055600723 CMS
Medtronic, Inc. $122.0610/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026337127 CMS
Axonics, Inc. $22.9008/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051778729 CMS
Intuitive Surgical, Inc. $280.4408/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055442789 CMS
Intuitive Surgical, Inc. $1,000.0008/10/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056017669 CMS
Intuitive Surgical, Inc. $407.0907/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055758924 CMS
Intuitive Surgical, Inc. $19.0007/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055926507 CMS
Medtronic, Inc. $14.7006/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026337125 CMS
Davol Inc. $1,000.0006/22/2023 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023919839 CMS
Medtronic, Inc. $51.9506/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026337121 CMS
Medtronic, Inc. $20.0406/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026337123 CMS
Medtronic, Inc. $34.6805/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026337119 CMS
Intuitive Surgical, Inc. $16.2504/15/2023 Gift No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055493785 CMS
Intuitive Surgical, Inc. $296.5504/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055673817 CMS
Davol Inc. $101.7004/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023919851 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,998.7503/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055374025 CMS
Intuitive Surgical, Inc. $19.0002/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055412299 CMS
Intuitive Surgical, Inc. $19.0002/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055416331 CMS
Intuitive Surgical, Inc. $220.9802/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055645493 CMS
Intuitive Surgical, Inc. $188.9002/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055954265 CMS
Medtronic, Inc. $736.0002/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1007517227 CMS
Medtronic, Inc. $94.7402/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026337117 CMS
Davol Inc. $1,000.0001/18/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023919827 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $120.42 2
PY2020 $220.00 1
PY2021 $5,291.15 5
PY2022 $16,303.53 17
PY2023 $7,818.14 24
PY2024 $2,612.71 15
PY2025 $357.46 10

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $89,345.50 7
PY2024 Principal investigator $37,270.82 15
PY2023 Principal investigator $20,802.60 6
PY2022 Principal investigator $27,782.21 8
PY2021 Principal investigator $117,673.37 17
PY2020 Principal investigator $15,664.23 14
PY2019 Recipient $108.18 2
PY2019 Principal investigator $17,505.47 558

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

560 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $59.05 11/08/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167629
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1.71 10/15/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167627
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $72.36 10/15/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167631
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $16.80 10/15/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167633
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $11.08 10/15/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167713
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $8.70 10/15/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167715
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $2.13 10/15/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167717
Principal investigator 1 Bausch Health US, LLC $675.00 07/01/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684364239
Recipient Takeda Pharmaceuticals U.S.A., Inc. $10.18 05/16/2019 Covered Recipient Physician Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686158185
Recipient Takeda Pharmaceuticals U.S.A., Inc. $98.00 05/16/2019 Covered Recipient Physician Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686158187
Principal investigator 1 Bausch Health US, LLC $15.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361239
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361243
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361247
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361251
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361255
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361259
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361263
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361267
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361275
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361279
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361283
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361287
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361291
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361297
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361299
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361301
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361305
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361313
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361317
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361321
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361325
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361329
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361333
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361337
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361339
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361343
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361349
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361353
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361355
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361359
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361363
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361366
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361369
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361373
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361375
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361379
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361385
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361390
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361395
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361401
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361405
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361409
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361413
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361417
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361421
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361425
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361429
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361435
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361439
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361443
Principal investigator 1 Bausch Health US, LLC $3.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361445
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361447
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361453
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361457
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361461
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361465
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361469
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361471
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361473
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361477
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361479
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361483
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361487
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361491
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361495
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361499
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361501
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361506
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361513
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361517
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361521
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361525
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361527
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361531
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361533
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361537
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361539
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361543
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361547
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361549
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361555
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361559
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361563
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361569
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361575
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361579
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361583
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361587
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361591
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361595
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361599
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361617
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361619
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361627
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361631
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361635
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361639
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361641
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361646
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361649
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361653
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361657
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361659
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361670
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361673
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361677
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361681
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361685
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361687
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361689
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361693
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361697
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361701
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361704
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361709
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361711
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361715
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361717
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361721
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361725
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361729
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361733
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361739
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361743
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361747
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361751
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361755
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361759
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361762
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361767
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361775
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361779
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361783
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361787
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361791
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361795
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361799
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361803
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361807
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361811
Principal investigator 1 Bausch Health US, LLC $3.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361815
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361821
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361823
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361827
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361831
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361835
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361841
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361847
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361851
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361853
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361857
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361861
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361865
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361869
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361872
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361877
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361881
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361885
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361887
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361891
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361893
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361897
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361899
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361905
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361909
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361911
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361915
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361919
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361923
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361925
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361929
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361933
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361935
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361939
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361943
Principal investigator 1 Bausch Health US, LLC $3.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361947
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361949
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361951
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361953
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361955
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361959
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361963
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361967
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361969
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361975
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361977
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361981
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361985
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361989
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361993
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361995
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684361999
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362003
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362007
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362011
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362013
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362019
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362025
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362029
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362031
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362035
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362039
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362045
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362048
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362053
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362055
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362058
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362063
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362065
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362069
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362073
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362078
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362083
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362087
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362091
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362095
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362099
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362103
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362107
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362111
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362117
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362119
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362121
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362125
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362129
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362136
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362140
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362143
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362145
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362147
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362151
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362155
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362157
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362161
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362165
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362169
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362173
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362177
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362181
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362185
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362187
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362191
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362193
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362197
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362199
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362201
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362203
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362207
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362211
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362215
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362221
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362223
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362227
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362231
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362235
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362239
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362243
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362248
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362253
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362257
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362261
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362263
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362267
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362271
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362275
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362279
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362283
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362287
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362291
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362295
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362301
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362305
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362309
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362313
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362315
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362319
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362323
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362327
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362331
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362335
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362339
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362343
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362347
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362351
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362355
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362359
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362363
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362367
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362371
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362373
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362377
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362379
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362383
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362387
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362391
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362393
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362397
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362401
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362405
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362409
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362413
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362417
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362421
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362427
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362431
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362435
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362439
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362443
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362445
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362449
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362453
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362457
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362461
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362467
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362471
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362475
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362479
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362483
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362487
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362491
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362495
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362497
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362501
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362505
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362509
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362513
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362515
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362519
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362523
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362527
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362529
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362533
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362537
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362541
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362545
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362549
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362553
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362557
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362561
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362565
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362569
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362573
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362577
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362581
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362585
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362589
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362595
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362597
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362601
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362605
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362609
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362613
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362617
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362621
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362623
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362627
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362631
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362635
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362639
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362643
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362647
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362654
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362659
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362663
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362667
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362671
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362675
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362679
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362681
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362685
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362689
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362693
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362697
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362703
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362705
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362709
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362713
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362717
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362721
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362725
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362727
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362731
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362735
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362739
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362743
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362746
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362751
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362755
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362758
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362761
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362765
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362771
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362775
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362777
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362781
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362787
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362791
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362793
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362797
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362799
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362803
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362807
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362809
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362813
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362817
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362821
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362825
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362829
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362831
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362835
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362839
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362843
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362846
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362850
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362855
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362859
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362861
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362864
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362869
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362873
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362877
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362881
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362885
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362889
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362893
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362897
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362901
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362905
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362909
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362913
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362917
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362920
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362923
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362927
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362931
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362935
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362939
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362943
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362947
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362951
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362953
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362957
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362961
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362963
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362967
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362970
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362975
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362977
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362983
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362987
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362991
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362994
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684362999
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363003
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363007
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363011
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363015
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363019
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363021
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363025
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363029
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363033
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363035
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363039
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363043
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363045
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363049
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363053
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363057
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363062
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363065
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363069
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363071
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363073
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363077
Principal investigator 1 Bausch Health US, LLC $25.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363081
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363085
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363089
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363093
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363097
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363101
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363105
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363111
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363115
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363117
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363121
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363125
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363129
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363133
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363135
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363141
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363145
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363151
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363155
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363159
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363163
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363169
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363175
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363179
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363183
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363187
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363189
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363193
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363195
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363199
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363203
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363205
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363207
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363211
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363215
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363219
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363221
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363225
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363229
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363233
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363235
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363237
Principal investigator 1 Bausch Health US, LLC $46.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363241
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363247
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363251
Principal investigator 1 Bausch Health US, LLC $6.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363254
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363258
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363263
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363268
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363273
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363275
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363279
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363283
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363287
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363291
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363295
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363299
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363303
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363309
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363313
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363317
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363321
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363325
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363329
Principal investigator 1 Bausch Health US, LLC $41.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363335
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363339
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363341
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363345
Principal investigator 1 Bausch Health US, LLC $5.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363347
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363349
Principal investigator 1 Bausch Health US, LLC $71.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363351
Principal investigator 1 Bausch Health US, LLC $30.00 04/27/2019 Non-covered Recipient Entity
CLEVELAND CLINIC FLORIDA
A PROSPECTIVE, SINGLE ARM, MULTICENTER, OBSERVATIONAL ASSESSMENT OF THE LONG TERM SAFETY AND EFFICACY OF SOLESTA INJECTABLE BULKING AGENT FOR THE TREATMENT OF FECAL INCONTINENCE SOFI No dispute reported 06/30/2026 684363353
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $173.00 03/30/2019 Non-covered Recipient Entity
Parexel International LLC
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167625
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $254.29 03/30/2019 Non-covered Recipient Entity
Parexel International LLC
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167719
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $496.35 03/30/2019 Non-covered Recipient Entity
Parexel International LLC
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II No dispute reported 06/30/2026 686167721